Patent US6152876A successfully refreshed from Google Patents.
US6152876A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for non-invasive blood analyte measurement with improved optical interface
Assignee: Rio Grande Medical Technologies Inc
•
Filing: 1998-10-19
•
Granted: 2000-11-28
•
Expires: 2018-10-19
Abstract
Abstract A method for non-invasively measuring the concentration of an analyte, particularly blood analyte in blood. The method utilizes spectrographic techniques in conjunction with an improved optical interface between a sensor probe and a skin surface or tissue surface of the body containing the blood to be analyzed. An index-matching medium is disclosed to improve the interface between the sensor probe and skin surface during spectrographic analysis. In a preferred embodiment, the blood analyte concentration in blood is quantified utilizing a partial squares analysis relative to a model incorporating analysis of plural known blood samples.
Inventors
- 👤 Mark Ries Robinson
- 👤 Robert G. Messerschmidt
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 15:12
CPC Classifications
A; A61; A61B; A61B5/00; A61B5/145; A61B5/1455; A61B5/14532; A61B2562/00; A61B2562/14; A61B2562/146
Claims Analysis
Total Claims: 46
Claim 1
Independent Claim
185 words
A non-invasive method for measuring the concentration of blood analyte in human tissue comprising the steps of: providing an apparatus for measuring infrared absorption, said apparatus including an energy source emitting infrared energy at multiple wavelengths, including selected wavelengths relevant to analyte concentration due to absorption by said analyte, operatively connected to an input element, said apparatus further including an output element operatively connected to a spectrum analyzer; providing an index-matching medium, said index-matching medium having minimal absorption of infrared energy at said selected wavelengths and a refractive index of between about 1.30 and 1.45, and disposing a quantity of said medium between said human tissue and said input element and output element to couple said elements to said analyte-containing tissue through said index-matching medium; and, irradiating said tissue through said input element with said multiple wavelengths of infrared energy so that there is differential absorption of at least some of said wavelengths; and, collecting at least a portion of the non-absorbed infrared energy with said output element for analysis of absorption with subsequent calculation of blood analyte concentration utilizing an algorithm and a model.
Claim 2
Dependent Claim
185 words
A non-invasive method for measuring the concentration of blood analyte in human tissue comprising the steps of: providing an apparatus for measuring infrared absorption, said apparatus including an energy source emitting infrared energy at multiple wavelengths, including selected wavelengths relevant to analyte concentration due to absorption by said analyte, operatively connected to an input element, said apparatus further including an output element operatively connected to a spectrum analyzer; providing an index-matching medium, said index-matching medium having minimal absorption of infrared energy at said selected wavelengths and a refractive index of between about 1.30 and 1.45, and disposing a quantity of said medium between said human tissue and said input element and output element to couple said elements to said analyte-containing tissue through said index-matching medium; and, irradiating said tissue through said input element with said multiple wavelengths of infrared energy so that there is differential absorption of at least some of said wavelengths; and, collecting at least a portion of the non-absorbed infrared energy with said output element for analysis of absorption with subsequent calculation of blood analyte concentration utilizing an algorithm and a model.
Claim 3
Dependent Claim
19 words
The method of claim 1, wherein said input element and output element are incorporated into a single sensor element.
Claim 4
Dependent Claim
22 words
The method of claim 1, wherein said index-matching medium has a refractive index closely matched to that of the tissue being irradiated.
Claim 5
Dependent Claim
16 words
The method of claim 1, wherein said index-matching medium further comprises a diagnostic additive dispersed therein.
Claim 6
Dependent Claim
25 words
The method of claim 4, wherein said diagnostic additive is a spectrographically active agent showing sharp absorbance at a wavelength other than said selected wavelengths.
Claim 7
Dependent Claim
22 words
The method of claim 4, wherein said diagnostic additive is selected from the group consisting of: perfluoro-2-butyltetrahydrofuran, perfluorosuccinyl chloride and mixtures thereof.
Claim 8
Dependent Claim
14 words
The method of claim 1, wherein said index-matching medium further comprises a physiological additive.
Claim 9
Dependent Claim
13 words
The method of claim 7, wherein said physiological additive is a vasodilating agent.
Claim 10
Dependent Claim
25 words
The method of claim 8, wherein said agent is selected from the group consisting of: methyl nicotinate, minoxidil, nitroglycerin, histamine, menthol, capsaicin and mixtures thereof.
Claim 11
Dependent Claim
169 words
A non-invasive method for measuring the concentration of blood analyte in human tissue comprising the steps of: providing an apparatus for measuring infrared absorption, said apparatus including an energy source emitting infrared energy at multiple wavelengths, including selected wavelengths relevant to analyte concentration due to absorption by said analyte, operatively connected to an input element, said apparatus further including an output element operatively connected to a spectrum analyzer; providing an index-matching medium, said index-matching medium including a chlorofluorocarbon polymer, and disposing a quantity of said medium between said human tissue and said input element and output element to couple said elements to said analyte-containing tissue through said index-matching medium; and, irradiating said tissue through said input element with said multiple wavelengths of infrared energy so that there is differential absorption of at least some of said wavelengths; and, collecting at least a portion of the non-absorbed infrared energy with said output element for analysis of absorption with subsequent calculation of blood analyte concentration utilizing an algorithm and a model.
Claim 12
Dependent Claim
169 words
A non-invasive method for measuring the concentration of blood analyte in human tissue comprising the steps of: providing an apparatus for measuring infrared absorption, said apparatus including an energy source emitting infrared energy at multiple wavelengths, including selected wavelengths relevant to analyte concentration due to absorption by said analyte, operatively connected to an input element, said apparatus further including an output element operatively connected to a spectrum analyzer; providing an index-matching medium, said index-matching medium including a chlorofluorocarbon polymer, and disposing a quantity of said medium between said human tissue and said input element and output element to couple said elements to said analyte-containing tissue through said index-matching medium; and, irradiating said tissue through said input element with said multiple wavelengths of infrared energy so that there is differential absorption of at least some of said wavelengths; and, collecting at least a portion of the non-absorbed infrared energy with said output element for analysis of absorption with subsequent calculation of blood analyte concentration utilizing an algorithm and a model.
Claim 13
Dependent Claim
19 words
The method of claim 10, wherein said input element and output element are incorporated into a single sensor element.
Claim 14
Dependent Claim
22 words
The method of claim 10, wherein said index-matching medium has a refractive index closely matched to that of the tissue being irradiated.
Claim 15
Dependent Claim
16 words
The method of claim 10, wherein said index-matching medium further comprises a diagnostic additive dispersed therein.
Claim 16
Dependent Claim
25 words
The method of claim 13, wherein said diagnostic additive is a spectrographically active agent showing sharp absorbance at a wavelength other than said selected wavelengths.
Claim 17
Dependent Claim
22 words
The method of claim 13, wherein said diagnostic additive is selected from the group consisting of: perfluoro-2-butyltetrahydrofuran, perfluorosuccinyl chloride and mixtures thereof.
Claim 18
Dependent Claim
14 words
The method of claim 10, wherein said index-matching medium further comprises a physiological additive.
Claim 19
Dependent Claim
13 words
The method of claim 16, wherein said physiological additive is a vasodilating agent.
Claim 20
Dependent Claim
25 words
The method of claim 17, wherein said agent is selected from the group consisting of methyl nicotinate, minoxidil, nitroglycerin, histamine, menthol, capsaicin and mixtures thereof.
Claim 21
Dependent Claim
174 words
A non-invasive method for measuring the concentration of blood analyte in human tissue comprising the steps of: providing an apparatus for measuring infrared absorption, said apparatus including an energy source emitting infrared energy at multiple wavelengths, including selected wavelengths relevant to analyte concentration due to absorption by said analyte, operatively connected to an input element, said apparatus further including an output element operatively connected to a spectrum analyzer; providing an index-matching medium, said index-matching medium including a chlorofluorocarbon polymer which is substantially spectroscopically inactive at said selected wavelengths, and disposing a quantity of said medium between said human tissue and said input element and output element to couple said elements to said analyte-containing tissue through said index-matching medium; and, irradiating said tissue through said input element with said multiple wavelengths of infrared energy so that there is differential absorption of at least some of said wavelengths; and, collecting at least a portion of the non-absorbed infrared energy with said output element followed by calculation of blood analyte concentration utilizing an algorithm and a model.
Claim 22
Dependent Claim
174 words
A non-invasive method for measuring the concentration of blood analyte in human tissue comprising the steps of: providing an apparatus for measuring infrared absorption, said apparatus including an energy source emitting infrared energy at multiple wavelengths, including selected wavelengths relevant to analyte concentration due to absorption by said analyte, operatively connected to an input element, said apparatus further including an output element operatively connected to a spectrum analyzer; providing an index-matching medium, said index-matching medium including a chlorofluorocarbon polymer which is substantially spectroscopically inactive at said selected wavelengths, and disposing a quantity of said medium between said human tissue and said input element and output element to couple said elements to said analyte-containing tissue through said index-matching medium; and, irradiating said tissue through said input element with said multiple wavelengths of infrared energy so that there is differential absorption of at least some of said wavelengths; and, collecting at least a portion of the non-absorbed infrared energy with said output element followed by calculation of blood analyte concentration utilizing an algorithm and a model.
Claim 23
Dependent Claim
19 words
The method of claim 19, wherein said input element and output element are incorporated into a single sensor element.
Claim 24
Dependent Claim
22 words
The method of claim 19, wherein said index-matching medium has a refractive index closely matched to that of the tissue being irradiated.
Claim 25
Dependent Claim
16 words
The method of claim 19, wherein said index-matching medium further comprises a diagnostic additive dispersed therein.
Claim 26
Dependent Claim
25 words
The method of claim 22, wherein said diagnostic additive is a spectrographically active agent showing sharp absorbance at a wavelength other than said selected wavelengths.
Claim 27
Dependent Claim
22 words
The method of claim 22, wherein said diagnostic additive is selected from the group consisting of: perfluoro-2-butyltetrahydrofuran, perfluorosuccinyl chloride and mixtures thereof.
Claim 28
Dependent Claim
14 words
The method of claim 19, wherein said index-matching medium further comprises a physiological additive.
Claim 29
Dependent Claim
13 words
The method of claim 25, wherein said physiological additive is a vasodilating agent.
Claim 30
Dependent Claim
25 words
The method of claim 26, wherein said agent is selected from the group consisting of methyl nicotinate, minoxidil, nitroglycerin, histamine, menthol, capsaicin and mixtures thereof.
Claim 31
Dependent Claim
61 words
A fluid composition for providing an optical interface between a skin surface on a body and a spectrographic sensor element when measuring the absorption of infrared energy by constituents under said skin surface within said body at selected multiple wavelengths, said fluid composition comprising: a non-toxic fluid having a refractive index greater than 1.0; and an effective amount of diagnostic additive.
Claim 32
Dependent Claim
61 words
A fluid composition for providing an optical interface between a skin surface on a body and a spectrographic sensor element when measuring the absorption of infrared energy by constituents under said skin surface within said body at selected multiple wavelengths, said fluid composition comprising: a non-toxic fluid having a refractive index greater than 1.0; and an effective amount of diagnostic additive.
Claim 33
Dependent Claim
26 words
The fluid composition of claim 28, wherein said diagnostic additive is a spectrographically active agent showing sharp absorbance at a wavelength other than said selected wavelengths.
Claim 34
Dependent Claim
23 words
The fluid composition of claim 29, wherein said diagnostic additive is selected from the group consisting of: perfluoro-2-butyltetrahydrofuran, perfluorosuccinyl chloride and mixtures thereof.
Claim 35
Dependent Claim
60 words
A fluid composition for providing an optical interface between a skin surface on a body and a spectrographic sensor element when measuring the absorption of infrared energy by constituents under said skin surface within said body at multiple wavelengths, said fluid composition comprising: a non-toxic fluid having a refractive index greater than 1.0; and an effective amount of physiological additive.
Claim 36
Dependent Claim
60 words
A fluid composition for providing an optical interface between a skin surface on a body and a spectrographic sensor element when measuring the absorption of infrared energy by constituents under said skin surface within said body at multiple wavelengths, said fluid composition comprising: a non-toxic fluid having a refractive index greater than 1.0; and an effective amount of physiological additive.
Claim 37
Dependent Claim
14 words
The fluid composition of claim 31, wherein said physiological additive is a vasodilating agent.
Claim 38
Dependent Claim
25 words
The fluid composition claim 32, wherein said agent is selected from the group consisting of: methyl nicotinate, minoxidil, nitroglycerin, histamine, menthol, capsaicin and mixtures thereof.
Claim 39
Dependent Claim
63 words
A fluid composition for providing an optical interface between a skin surface on a body and a spectrographic sensor element when measuring the absorption of infrared energy by constituents under said skin surface within said body at selected multiple wavelengths, said fluid composition comprising: about 80% to about 99.8% of a chlorofluorocarbon polymer; and about 0.2% to about 20% of a diagnostic additive.
Claim 40
Dependent Claim
63 words
A fluid composition for providing an optical interface between a skin surface on a body and a spectrographic sensor element when measuring the absorption of infrared energy by constituents under said skin surface within said body at selected multiple wavelengths, said fluid composition comprising: about 80% to about 99.8% of a chlorofluorocarbon polymer; and about 0.2% to about 20% of a diagnostic additive.
Claim 41
Dependent Claim
26 words
The fluid composition of claim 34, wherein said diagnostic additive is a spectrographically active agent showing sharp absorbance at a wavelength other than said selected wavelengths.
Claim 42
Dependent Claim
23 words
The fluid composition of claim 35, wherein said diagnostic additive is selected from the group consisting of: perfluoro-2-butyltetrahydrofuran, perfluorosuccinyl chloride and mixtures thereof.
Claim 43
Dependent Claim
62 words
A fluid composition for providing an optical interface between a skin surface on a body and a spectrographic sensor element when measuring the absorption of infrared energy by constituents under said skin surface within said body at multiple wavelengths, said fluid composition comprising: about 80% to about 99.8% of a chlorofluorocarbon polymer; and about 0.2% to about 20% of a physiological additive.
Claim 44
Dependent Claim
62 words
A fluid composition for providing an optical interface between a skin surface on a body and a spectrographic sensor element when measuring the absorption of infrared energy by constituents under said skin surface within said body at multiple wavelengths, said fluid composition comprising: about 80% to about 99.8% of a chlorofluorocarbon polymer; and about 0.2% to about 20% of a physiological additive.
Claim 45
Dependent Claim
14 words
The fluid composition of claim 37, wherein said physiological additive is a vasodilating agent.
Claim 46
Dependent Claim
25 words
The fluid composition claim 38, wherein said agent is selected from the group consisting of: methyl nicotinamide, minoxidil, nitroglycerin, histamine, menthol, capsaicin and mixtures thereof.
References Cited (Backward Citations)
US3508830A
Cited
US4169807A
Cited
US4661706A
Cited
US4655225A
Cited
EP0280418A1
Cited
US4853542A
Cited
US4882492A
Cited
US5028787A
Cited
US4975581A
Cited
US5070874A
Cited
US5222496A
Cited
US5015100A
Cited
US5019715A
Cited
US5237178A
Cited
US5158082A
Cited
WO1992017765A1
Cited
US5299570A
Cited
WO1993007801A1
Cited
US5372135A
Cited
US5355880A
Cited
US5321265A
Cited
US5452723A
Cited
US5348003A
Cited
US5379764A
Cited
US5402778A
Cited
US5533509A
Cited
US5505726A
Cited
US5636633A
Cited
US5655530A
Cited
US5823951A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2003-11-28 | 2004-05-29 | 2004-11-28 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2007-11-28 | 2008-05-29 | 2008-11-28 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2011-11-28 | 2012-05-29 | 2012-11-28 | $7700.00 | Window Closed / Lapsed |